Skip to main content
Erschienen in: Clinical & Experimental Metastasis 6/2014

01.08.2014

Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis

verfasst von: Xiangmin Zhao, Gabriel Rezonzew, Dezhi Wang, Gene P. Siegal, Robert W. Hardy

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

A significant percentage of breast cancer victims will suffer from metastases indicating that new approaches to preventing breast cancer metastasis are thus needed. Dietary stearate (ST) and chemotherapy have been shown to reduce breast cancer metastasis. We tested the complementary use of dietary ST with a taxol-based chemotherapy which work through separate mechanisms to reduce breast cancer metastasis. We therefore carried out a prevention study in which diets were initiated prior to human MDA-MB-435 cancer cells being injected into the host and a treatment study in which diets were combined with paclitaxel (PTX). Using an orthotopic athymic nude mouse model and three diets [corn oil (CO) control diet, low fat (LF) or ST] the prevention study demonstrated that the ST diet decreased the incidence of lung metastasis by 50 % compared to both the LF and CO diets. The ST diet also reduced the number and size of metastatic lung nodules compared to the LF diet. Results of the treatment study indicated that both the CO and ST diets decreased the number of mice with lung metastasis compared to the LF diet. Both CO and ST also decreased the number of lung metastases per mouse compared to the LF diet however only the ST diet cohort was significant. Histomorphometric analysis of the lung tumor tissue indicated that the ST diet plus PTX decreased angiogenesis compared to the LF diet plus PTX. In conclusion these results support combining diet with chemotherapy in both treatment and prevention settings.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef
2.
Zurück zum Zitat Saloustros E, Mavroudis D, Georgoulias V (2008) Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Pharmacother 9:2603–2616PubMedCrossRef Saloustros E, Mavroudis D, Georgoulias V (2008) Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Pharmacother 9:2603–2616PubMedCrossRef
3.
Zurück zum Zitat Pienta K (2001) Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer. Semin Oncol 28(4 Suppl 15):3–7PubMedCrossRef Pienta K (2001) Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer. Semin Oncol 28(4 Suppl 15):3–7PubMedCrossRef
4.
Zurück zum Zitat Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22:6524–6536PubMedCrossRef Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22:6524–6536PubMedCrossRef
5.
Zurück zum Zitat Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef
6.
Zurück zum Zitat Chung CT, Carlson RW (2003) Goals and objectives in the management of metastatic breast cancer. Oncologist 8:514–520PubMedCrossRef Chung CT, Carlson RW (2003) Goals and objectives in the management of metastatic breast cancer. Oncologist 8:514–520PubMedCrossRef
7.
Zurück zum Zitat Grundy SM (1994) Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids. Am J Clin Nutr 60:986S–990SPubMed Grundy SM (1994) Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids. Am J Clin Nutr 60:986S–990SPubMed
8.
Zurück zum Zitat Hunter JE, Zhang J, Kris-Etherton PM (2010) Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91:46–63PubMedCrossRef Hunter JE, Zhang J, Kris-Etherton PM (2010) Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91:46–63PubMedCrossRef
9.
Zurück zum Zitat Tinsley IJ, Schmitz JA, Pierce DA (1981) Influence of dietary fatty acids on the incidence of mammary tumors in the C3H mouse. Cancer Res 41:1460–1465PubMed Tinsley IJ, Schmitz JA, Pierce DA (1981) Influence of dietary fatty acids on the incidence of mammary tumors in the C3H mouse. Cancer Res 41:1460–1465PubMed
10.
Zurück zum Zitat Bennett AS (1984) Effect of dietary stearic acid on the genesis of spontaneous mammary adenocarcinomas in strain A/ST mice. Int J Cancer 34:529–533PubMed Bennett AS (1984) Effect of dietary stearic acid on the genesis of spontaneous mammary adenocarcinomas in strain A/ST mice. Int J Cancer 34:529–533PubMed
11.
Zurück zum Zitat Habib NA, Wood CB, Apostolov K, Barker W, Hershman MJ, Aslam M, Heinemann D, Fermor B, Williamson RC, Jenkins WE et al (1987) Stearic acid and carcinogenesis. Br J Cancer 56:455–458PubMedCrossRefPubMedCentral Habib NA, Wood CB, Apostolov K, Barker W, Hershman MJ, Aslam M, Heinemann D, Fermor B, Williamson RC, Jenkins WE et al (1987) Stearic acid and carcinogenesis. Br J Cancer 56:455–458PubMedCrossRefPubMedCentral
12.
Zurück zum Zitat Singh RK, Hardy RW, Wang MH, Williford J, Gladson CL, McDonald JM, Siegal GP (1995) Stearate inhibits human tumor cell invasion. Invasion Metastasis 15:144–155PubMed Singh RK, Hardy RW, Wang MH, Williford J, Gladson CL, McDonald JM, Siegal GP (1995) Stearate inhibits human tumor cell invasion. Invasion Metastasis 15:144–155PubMed
13.
Zurück zum Zitat Wickramasinghe NS, Jo H, McDonald JM, Hardy RW (1996) Stearate inhibition of breast cancer cell proliferation. A mechanism involving epidermal growth factor receptor and G-proteins. Am J Pathol 148:987–995PubMedPubMedCentral Wickramasinghe NS, Jo H, McDonald JM, Hardy RW (1996) Stearate inhibition of breast cancer cell proliferation. A mechanism involving epidermal growth factor receptor and G-proteins. Am J Pathol 148:987–995PubMedPubMedCentral
14.
Zurück zum Zitat Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y (2003) Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 278:31861–31870PubMedCrossRef Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y (2003) Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 278:31861–31870PubMedCrossRef
15.
16.
Zurück zum Zitat Evans LM, Toline EC, Desmond R, Siegal GP, Hashim AI, Hardy RW (2009) Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice. Clin Exp Metastasis 26:415–424PubMedCrossRefPubMedCentral Evans LM, Toline EC, Desmond R, Siegal GP, Hashim AI, Hardy RW (2009) Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice. Clin Exp Metastasis 26:415–424PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat Li C, Zhao X, Toline E, Siegal GP, Evans LM, Ibrahim-Hashim A, Desmond R, Hardy RW (2011) Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate. Carcinogenesis 32:1251–1258PubMedCrossRefPubMedCentral Li C, Zhao X, Toline E, Siegal GP, Evans LM, Ibrahim-Hashim A, Desmond R, Hardy RW (2011) Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate. Carcinogenesis 32:1251–1258PubMedCrossRefPubMedCentral
18.
Zurück zum Zitat Townson JL, Naumov GN, Chambers AF (2003) The role of apoptosis in tumor progression and metastasis. Curr Mol Med 3:631–642PubMedCrossRef Townson JL, Naumov GN, Chambers AF (2003) The role of apoptosis in tumor progression and metastasis. Curr Mol Med 3:631–642PubMedCrossRef
19.
Zurück zum Zitat Boedefeld WM II, Bland KI, Heslin MJ (2003) Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma. Ann Surg Oncol 10:839–851PubMedCrossRef Boedefeld WM II, Bland KI, Heslin MJ (2003) Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma. Ann Surg Oncol 10:839–851PubMedCrossRef
20.
Zurück zum Zitat Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180PubMedCrossRef Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180PubMedCrossRef
22.
Zurück zum Zitat Schmitz AA, Govek EE, Böttner B, Van Aelst L (2000) Rho GTPases: signaling, migration, and invasion. Exp Cell Res 25:1–12CrossRef Schmitz AA, Govek EE, Böttner B, Van Aelst L (2000) Rho GTPases: signaling, migration, and invasion. Exp Cell Res 25:1–12CrossRef
23.
Zurück zum Zitat Merajver SD, Usmani SZ (2005) Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia 10:291–298PubMedCrossRef Merajver SD, Usmani SZ (2005) Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia 10:291–298PubMedCrossRef
24.
Zurück zum Zitat Pillé JY, Denoyelle C, Varet J et al (2005) Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 11:267–274PubMedCrossRef Pillé JY, Denoyelle C, Varet J et al (2005) Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 11:267–274PubMedCrossRef
25.
Zurück zum Zitat Welsch CW (1992) Dietary fat, calories, and mammary gland tumorigenesis. Adv Exp Med Biol 322:203–222PubMedCrossRef Welsch CW (1992) Dietary fat, calories, and mammary gland tumorigenesis. Adv Exp Med Biol 322:203–222PubMedCrossRef
26.
Zurück zum Zitat Rose DP, Connolly JM (1992) Influence of dietary fat intake on local recurrence and progression of metastases arising from MDA-MB-435 human breast cancer cells in nude mice after excision of the primary tumor. Nutr Cancer 18:113–122PubMedCrossRef Rose DP, Connolly JM (1992) Influence of dietary fat intake on local recurrence and progression of metastases arising from MDA-MB-435 human breast cancer cells in nude mice after excision of the primary tumor. Nutr Cancer 18:113–122PubMedCrossRef
28.
Zurück zum Zitat Klement RJ, Kammerer U (2011) Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab 8:75CrossRef Klement RJ, Kammerer U (2011) Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab 8:75CrossRef
29.
Zurück zum Zitat Saadatian-Elahi M, Norat T, Goudable J, Riboli E (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111:584–591PubMed Saadatian-Elahi M, Norat T, Goudable J, Riboli E (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111:584–591PubMed
30.
Zurück zum Zitat Munaron L (2006) Intracellular calcium, endothelial cells and angiogenesis. Recent Pat Anticancer Drug Discov 1:105–119PubMedCrossRef Munaron L (2006) Intracellular calcium, endothelial cells and angiogenesis. Recent Pat Anticancer Drug Discov 1:105–119PubMedCrossRef
31.
Zurück zum Zitat Naumova E, Ubezio P, Garofalo A et al (2006) The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Clin Cancer Res 12:1839–1849PubMedCrossRef Naumova E, Ubezio P, Garofalo A et al (2006) The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Clin Cancer Res 12:1839–1849PubMedCrossRef
32.
Zurück zum Zitat Dong LF, Swettenham E, Eliasson J et al (2007) Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res 67:11906–11913PubMedCrossRef Dong LF, Swettenham E, Eliasson J et al (2007) Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res 67:11906–11913PubMedCrossRef
33.
Zurück zum Zitat Artwohl M, Roden M, Waldhäusl W et al (2004) Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J 18:146–158PubMed Artwohl M, Roden M, Waldhäusl W et al (2004) Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J 18:146–158PubMed
34.
Zurück zum Zitat Artwohl M, Lindenmair A, Sexl V et al (2008) Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells. J Lipid Res 49:2627–2640PubMedCrossRef Artwohl M, Lindenmair A, Sexl V et al (2008) Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells. J Lipid Res 49:2627–2640PubMedCrossRef
35.
Zurück zum Zitat Chambers AF (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69:5292–5293PubMedCrossRef Chambers AF (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69:5292–5293PubMedCrossRef
36.
Zurück zum Zitat Nerlich AG, Bachmeier BE (2013) Density-dependent lineage instability of MDA-MB-435 breast cancer cells. Oncol Lett 5:1370–1374PubMedPubMedCentral Nerlich AG, Bachmeier BE (2013) Density-dependent lineage instability of MDA-MB-435 breast cancer cells. Oncol Lett 5:1370–1374PubMedPubMedCentral
37.
Zurück zum Zitat Rae JM, Creighton CJ, Meck JM et al (2007) MDA-MB-435 cells are derived from M14 melanoma cells: a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104:13–19PubMedCrossRef Rae JM, Creighton CJ, Meck JM et al (2007) MDA-MB-435 cells are derived from M14 melanoma cells: a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104:13–19PubMedCrossRef
38.
Zurück zum Zitat Christgen M, Lehmann U (2007) MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoing. Cancer Biol Ther 6:1355–1357PubMedCrossRef Christgen M, Lehmann U (2007) MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoing. Cancer Biol Ther 6:1355–1357PubMedCrossRef
Metadaten
Titel
Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis
verfasst von
Xiangmin Zhao
Gabriel Rezonzew
Dezhi Wang
Gene P. Siegal
Robert W. Hardy
Publikationsdatum
01.08.2014
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 6/2014
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-014-9654-5

Weitere Artikel der Ausgabe 6/2014

Clinical & Experimental Metastasis 6/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.